Controversies in Skin Surgery: Electrodessication and Curettage Versus Excision for Low-risk, Small, Well-differentiated Squamous Cell Carcinomas
Overview
Authors
Affiliations
Background: Electrodesiccation and curettage (ED&C) of low-risk, cutaneous squamous cell carcinoma (SCC) generally consumes less time and resources than excision. Review of the literature reveals few recent studies examining cure rates for ED&C in the treatment of low risk cutaneous SCC.
Objective: To evaluate via two retrospective studies the efficacy of ED&C in the treatment of low risk cutaneous SCC.
Methods: A small controlled study in a Veterans Administration teaching hospital dermatology clinic compared cure rates of low risk SCC at one year by ED&C to those of surgical excision. A second study examined the cure rate of low risk lesions treated by curettage and electrodesiccation in a private practice.
Results: The first study found no significant difference in cure rates between ED&C (14 of 14 cases successfully treated) and excision (15 of 16 successfully treated and one recurrence) (P = 0.1711). The second study found the ED&C cure rate (106 of 106 successfully treated) to be significantly greater than an arbitrary cure rate of 95 percent (P = 0.0091).
Conclusion: These findings support the efficacy of ED&C as a treatment modality for low-risk cutaneous SCC.
Hasan N, Nadaf A, Imran M, Jiba U, Sheikh A, Almalki W Mol Cancer. 2023; 22(1):168.
PMID: 37803407 PMC: 10559482. DOI: 10.1186/s12943-023-01854-3.
Nemer K, Bauman T, Council M, Hurst E Int J Womens Dermatol. 2020; 6(2):99-101.
PMID: 32258341 PMC: 7105649. DOI: 10.1016/j.ijwd.2019.10.005.
Hyfrecation for recalcitrant nongenital warts.
Leung L J Family Med Prim Care. 2014; 2(2):141-4.
PMID: 24479067 PMC: 3894036. DOI: 10.4103/2249-4863.117403.
Lansbury L, Bath-Hextall F, Perkins W, Stanton W, Leonardi-Bee J BMJ. 2013; 347:f6153.
PMID: 24191270 PMC: 3816607. DOI: 10.1136/bmj.f6153.